Business Standard

Cough syrup deaths in the Gambia serious issue, says WHO chief scientist

Swaminathan was speaking to reporters on Thursday on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) here

cough syrup, medicine, cold
Premium

File photo of cough syrup. Photo: Shutterstock

Press Trust of India
Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan has said the death of children in the Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.
 
Swaminathan was speaking to reporters on Thursday on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) here.
 
A WHO report has linked the death of 66 children in the Gambia to four Indian-made cough syrups.
 
"Certainly, the government is in touch with WHO as WHO actually provided the report based on the investigation which was done to prove that it was because

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in